{"timestamp": 1771603684.7636738, "value": {"ticker": "MYGN", "company_name": "Myriad Genetics, Inc.", "short_name": "Myriad Genetics, Inc.", "sector": "Healthcare", "industry": "Diagnostics & Research", "country": "United States", "market_cap": 402217216, "float_shares": 79135654, "shares_outstanding": 93213722, "short_ratio": 11.99, "short_percent_of_float": 0.1607, "shares_short": 10659674, "shares_short_prior": 9635344, "insider_percent_held": 0.02842, "institution_percent_held": 1.04003, "total_cash": 145400000, "total_debt": 212300000, "total_revenue": 825299968, "revenue_growth": -0.036, "earnings_growth": 0, "profit_margins": -0.48528, "gross_margins": 0.70362, "operating_margins": -0.11327, "debt_to_equity": 56.947, "current_ratio": 2.33, "book_value": 4.004, "price_to_book": 1.0776722, "operating_cashflow": -2200000, "free_cashflow": 9537500, "price": 4.315, "52w_high": 15.47, "52w_low": 3.76, "avg_volume": 993616, "avg_volume_10d": 1048890, "full_time_employees": 2700, "audit_risk": 7, "overall_risk": 3}}